Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
about
Account for Clinical Heterogeneity in Assessment of Catheter-based Renal Denervation among Resistant Hypertension Patients: Subgroup Meta-analysis.Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension.Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence.Should All Patients with Resistant Hypertension Receive Spironolactone?Multidisciplinary Approach in the Treatment of Resistant Hypertension.Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis.How to perform a cost-effectiveness analysis with surrogate endpoint: renal denervation in patients with resistant hypertension (DENERHTN) trial as an example.Resistant hypertension: a therapeutic challenge.Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.Prevalence and Clinical Characteristics of Refractory Hypertension.Renal Denervation vs. Spironolactone in Resistant Hypertension: Effects on Circadian Patterns and Blood Pressure Variability.[Invasive treatment of hypertension : Update 2016].Characteristics and treatment of African-American and European-American patients with resistant hypertension identified using the electronic health record in an academic health centre: a case-control study.
P2860
Q33864742-EE52937F-CB81-425E-8F10-E592DB64C419Q38685633-8E916C42-D0E2-42C9-82F1-E57B44BF23CEQ38871976-F0A262EF-BC44-447A-BFF1-33EF100E5BE8Q38919250-8E93935E-9579-429A-9FF1-93991615CE1FQ38992649-7362FCDB-422C-4199-90E8-066EA4A97C90Q39129288-8157B59F-1A1E-4507-B072-FD76278CB605Q40227792-9D8D9437-2EFA-49B7-86B0-26E9DB4E8F77Q47718878-4CBC7D87-1B1F-4633-9B94-06494898D242Q48279650-176AE333-8BB4-420D-A4C1-1F562FFBDC3DQ48279889-F9F1223A-2B4E-44F3-B707-79B4720DD55AQ49165704-0E84485B-0F6D-44E4-9505-E9069CFBA509Q53769038-60352E85-5A8D-41C4-894E-685FC63BA0C7Q53772555-966EFCFA-EA84-4A5F-A4F9-F581091BFAA5Q55396649-1A7C17FE-AC21-4BDA-9878-585560C44621
P2860
Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Spironolactone versus sympathe ...... a randomized controlled trial.
@en
Spironolactone versus sympathe ...... a randomized controlled trial.
@nl
type
label
Spironolactone versus sympathe ...... a randomized controlled trial.
@en
Spironolactone versus sympathe ...... a randomized controlled trial.
@nl
prefLabel
Spironolactone versus sympathe ...... a randomized controlled trial.
@en
Spironolactone versus sympathe ...... a randomized controlled trial.
@nl
P2093
P2860
P1476
Spironolactone versus sympathe ...... a randomized controlled trial
@en
P2093
Albert Clarà
Alejandro De la Sierra
Julio Pascual
Laia Sans-Atxer
Pedro Armario
Susana Vázquez
P2860
P304
P356
10.1097/HJH.0000000000001025
P577
2016-09-01T00:00:00Z